Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | FYN | P06241 | 2/20 | 0.35 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1764717 | 0.83 | CNR1 (0.34) | ALDH1A1HPGDALOX15HSD17B10EGFR | |
| SCHEMBL29913397 | 0.79 | ADAMTS4 (0.32) | ALDH1A1HPGDALOX15HSD17B10EGFR | |
| SCHEMBL1980294 | 0.79 | ADAMTS4 (0.32) | ALDH1A1HPGDALOX15HSD17B10EGFR | |
| SCHEMBL18199055 | 0.72 | TMEM97 (0.32) | KDM4E | |
| SCHEMBL28085951 | 0.72 | ALDH1A1 (0.34) | ALDH1A1HPGDHSD17B10SMN1; SMN2MEN1 | |
| SCHEMBL9904685 | 0.69 | ITGB2 (0.38) | ALDH1A1HPGDALOX15HSD17B10EGFR | |
| SCHEMBL16661511 | 0.68 | ITGB2 (0.37) | LMNAITGB2ICAM1ITGALMAPT | |
| SCHEMBL21953275 | 0.68 | TYR (0.33) | ALDH1A1HPGDALOX15HSD17B10CA2 | |
| SCHEMBL22467586 | 0.66 | DRD1 (0.41) | TDP1ABCG2ITGB2ICAM1ITGAL | |
| SCHEMBL9833025 | 0.65 | ABCG2 (0.42) | LMNAABCG2ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185835-A1 | SYNTHESIS AND USE OF OXA-SPIRODIPHOSPHINE LIGAND | SHENZHEN CATALYS TECHNOLOGY CO., LTD (CN) | 2022-06-16 | — | — | US | disclosed |
| US-11299507-B2 | Synthesis and use of oxa-spirodiphosphine ligand | SHENZHEN CATALYS TECHNOLOGY CO., LTD. (CN) | 2022-04-12 | — | — | US | disclosed |
| EP-3730502-A1 | SYNTHESIS AND APPLICATION OF OXASPIROCYCLODIPHOSPHINE LIGAND | SHENZHEN CATALYS TECHNOLOGY CO., LTD. (CN) | 2020-10-28 | — | — | EP | disclosed |
| US-20200308206-A1 | SYNTHESIS AND USE OF OXA-SPIRODIPHOSPHINE LIGAND | SHENZHEN CATALYS TECHNOLOGY CO., LTD (CN) | 2020-10-01 | — | — | US | disclosed |
| WO-2019153203-A1 | SYNTHESIS AND APPLICATION OF OXASPIROCYCLODIPHOSPHINE LIGAND | 凯特立斯(深圳)科技有限公司 | 2019-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308206-A1 | SYNTHESIS AND USE OF OXA-SPIRODIPHOSPHINE LIGAND | OXER1, OXGR1, PTMS | ALDH1A1 683/4885HPGD 1016/4885ALOX15 1373/4885 |
| US-20220185835-A1 | SYNTHESIS AND USE OF OXA-SPIRODIPHOSPHINE LIGAND | OXER1, OXGR1, ICOSLG | ALDH1A1 784/4885HPGD 950/4885ALOX15 967/4885 |
| US-11299507-B2 | Synthesis and use of oxa-spirodiphosphine ligand | OXER1, OXGR1, FOXO1 | ALDH1A1 686/4885HPGD 997/4885ALOX15 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.